Max Financial Services / Q1-FY26

MFSL Q1 FY26 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveCall date pendingBack to MFSL

Revenue

₹12,822 Cr

verified against source

Revenue YoY

18%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
Revenue (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly Revenue (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY26: 12,822 · Positive source sentimentQ1 FY26Q2 FY26: 9,792 · Positive source sentiment · 2025-09-30Q2 FY26Q3 FY26: 14,259 · Positive source sentiment · 2025-12-31Q3 FY2614,2599,792
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Max Financial Services delivered a strong Q1 FY26 with 18% revenue growth to ₹6,194 crore and 32% PAT growth to ₹86 crore, driven by exceptional 23% growth in individual adjusted first-year premium—nearly 3x the private sector's 8%. The VNB margin expanded 260bps YoY to 20.1%, enabling 32% VNB growth to ₹335 crore. The product mix shift away from ULIPs (down from 43% to 36%) toward protection (26% growth) and annuities (40% growth) is driving margin expansion, with rider AP surging over 300%. Management reiterated FY26 margin guidance of 24-25% and remains confident in sustaining growth momentum across proprietary (18% AP growth) and bank assurance (16%) channels. Key risks include persistency pressure on 13th-month cohorts and regulatory uncertainty around the insurance bill's merger provisions. The upcoming MD transition in October adds near-term execution uncertainty.

Colored figures show movement against the previous available record.

Guidance to track

  • Management expressed reasonable confidence to maintain margin guidance of 24-25% for FY26 while continuing to invest in distribution channels, building on the 20.1% Q1 margin.
  • The delta between Annual Premium Equivalent and Adjusted Individual First-year Premium will plateau at 2-4% going forward from the current higher differential caused by ULIP moderation in online channel.

Risks flagged

  • 13th month persistency declined to 86% from 87% YoY due to economic pressure on Indian consumers and reduced high-ticket size sales. Management is closely monitoring this trend for potential EV walk negative variance.
  • Online AP remained flattish due to market volatility impacting ULIP demand. While management expects recovery through innovative product features combining guarantees and protection, the timeline remains uncertain.
  • Media speculation about regulatory changes to Section 35 provisions regarding insurance-non-insurance mergers remains unresolved despite management's view that the holding company structure poses no issues.
  • Regulatory changes on October 1st impacted fixed benefit health plans, causing degrowth in the health protection sub-segment that offset strong pure protection performance.

Key quotes

  • We have carried forward our strong growth momentum into quarter 1 of FY26 also delivering healthy growth while balancing the needs of our customers, partners, shareholders and employees.
  • This launch has helped us rebalance our product mix reducing the share of ULIPS from 43% in quarter 1 last year to 36% this quarter.
  • We would like to remain in this healthy range of margins which is between 24-25%, if we see margins actually running up ahead of that we will be very keen on blowing that back into the business for growth purposes.

Research modules

Go one layer deeper.